Items where authors include "Kuwana, M."

Article

Bjørkekjær, H.J., Bruni, C., Broch, K. et al. (60 more authors) (2025) A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. Rheumatology. keaf053. ISSN 1462-0324

Roth, E., Bruni, C., Petelytska, L. et al. (244 more authors) (2025) Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology. keaf016. ISSN 1462-0324

Colalillo, A., Hachulla, E., Pellicano, C. et al. (35 more authors) (2024) Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. Chest Journal, 166 (4). pp. 837-844. ISSN 0012-3692

Khanna, D., Denton, C.P., Assassi, S. et al. (12 more authors) (2024) A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale. Clinical and Experimental Rheumatology, 42 (8). pp. 1635-1644. ISSN 0392-856X

Velauthapillai, A., Bootsma, M.F.R., Bruni, C. et al. (118 more authors) (2024) Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. Rheumatology. keae375. ISSN 1462-0324

Andreoli, L., Lini, D., Schreiber, K. et al. (184 more authors) (2024) COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. Rheumatology, 63 (5). pp. 1341-1351. ISSN 1462-0324

Yoshida, A., Li, Y., Maroufy, V. et al. (184 more authors) (2024) Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey. Rheumatology Advances in Practice, 8 (2). rkae028. ISSN 2514-1775

Deibel, E. orcid.org/0000-0003-4652-9826, Carreira, P.E., Vonk, M. orcid.org/0000-0002-2266-9907 et al. (61 more authors) (2024) Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? Arthritis Care & Research, 76 (1). pp. 88-97. ISSN 2151-464X

Lescoat, A., Bellando-Randone, S., Campochiaro, C. et al. (9 more authors) (2023) Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine. The Lancet Rheumatology, 5 (11). e683-e694. ISSN 2665-9913

Spiera, R. orcid.org/0000-0003-2911-6800, Kuwana, M. orcid.org/0000-0001-8352-6136, Khanna, D. orcid.org/0000-0003-1412-4453 et al. (28 more authors) (2023) Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology, 75 (9). pp. 1608-1618. ISSN 2326-5191

Colalillo, A., Pellicano, C., Ananyeva, L.P. et al. (12 more authors) (2023) Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. Arthritis Care & Research. ISSN 2151-464X

Lescoat, A., Huang, S., Carreira, P.E. et al. (219 more authors) (2023) Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatology, 159 (8). pp. 837-847. ISSN 2168-6068

Hughes, M., Huang, S., Alegre-Sancho, J.J. et al. (98 more authors) (2023) Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology, 62 (SI). SI54-SI63. ISSN 1462-0324

Garaiman, A., Steigmiller, K., Gebhard, C. et al. (171 more authors) (2023) Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology, 62 (SI). SI91-SI100. ISSN 1462-0324

Kuster, S., Jordan, S., Elhai, M. et al. (104 more authors) (2022) Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open, 8 (2). e002477. ISSN 2056-5933

Kakkar, V., Assassi, S., Allanore, Y. et al. (4 more authors) (2022) Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit. Current Opinion in Rheumatology, 34 (6). pp. 357-364. ISSN 1040-8711

Hughes, M., Allanore, Y., Baron, M. et al. (13 more authors) (2022) Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. The Lancet Rheumatology, 4 (11). e795-e803. ISSN 2665-9913

Elhai, M., Sritharan, N., Boubaya, M. et al. (167 more authors) (2022) Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology, 4 (11). e785-e794. ISSN 2665-9913

Proceedings Paper

Bruni, C., Tofani, L., Fretheim, H. et al. (55 more authors) (2023) OP0238 Immunosuppression With Targeted Dmards Reduces Morbidity And Mortality In Pre-Capillary Pulmonary Hypertension Associated With Systemic Sclerosis: A Eustar Analysis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 157-159.